Skip to content
Monday, November 9, 2026
GoldenHub

Zimbabwe Rejects ‘Lopsided’ US Healthcare Assistance Agreement Due to Data Concerns

Medical funding image
The proposed US funding would have supported programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a major US health deal worth 367 million US dollars (272 million pounds) spanning five years due to the United States' demand for confidential biological samples.

This rejection was revealed following a official document dated December was leaked, which showed President Emmerson Mnangagwa deemed the agreement was "unbalanced".

An official spokesperson has since stated that the United States was requesting health data for scientific study and commercial gain while was not willing to share the benefits from future vaccines.

"We must now begin the difficult and regrettable process of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has urged continued talks to secure a agreement agreeable to both sides so the nation's vital HIV treatment initiative can be sustained.

Broader Background

This development follows a comparable situation in neighbouring Kenya, where a court suspended a similar deal with the US following concerns were raised about the security of citizens' medical information.

Since resuming office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

USAID had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his government was seeking government-to-government deals to enhance transparency and responsibility.

As per reports, 16 African countries have so far agreed to these new health pacts, constituting more than $18.3bn in committed funds.

Details of the Rejected Agreement

This assistance for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"It is our view this collaboration would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment via US-supported initiatives," Tremont added.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"Zimbabwe was being asked to surrender its genetic material and health information for a long time, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that could result from that shared data," Mangwana explained.

"Put simply, our nation would supply the basic resources for medical research with no certainty that the resulting innovations would be accessible to our people if a future disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting structures already set up via the global health agency.

Mangwana cited its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.

"This system is designed to ensure that when a country contributes its information, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the capability to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," he added.

"We are open to further dialogue with our American counterparts on how subsequent collaboration could be designed in a way that honours the sovereignty and dignity of both nations."

Medical Community Reaction

Medical experts said it acknowledged the official position, but urged that talks should continue given that a large portion of the nation's HIV programmes relied on international support.

"If specific concerns arise, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group added.

The halted deal highlights the ongoing challenges between receiving crucial foreign assistance and safeguarding a country's data in an ever more data-driven world.

Written by

Robert Hill

Maya Chen is a tech journalist and digital strategist with over a decade of experience covering emerging technologies and startup ecosystems.

GoldenHub

Type to search articles.